Stock NCNA NUCANA PLC
Add to a list
To use this feature you must be a member
Log inSign up

Consensus NuCana plc

Equities

NCNA

US67022C2052

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-01 pm EDT 		5-day change 1st Jan Change
3.98 USD +0.51% Intraday chart for NuCana plc +3.65% -46.18%
May. 01 European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading MT
Apr. 26 European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4% MT

Evolution of the average Target Price on NuCana plc

Price target over the last 5 years

History of analyst recommendation changes

0c3454f008e2843e8ee40a99a6c786.3cdmeKR0gopBsBWR3e5nRuyawbTa6ma2W1flCdVHMQI.k6wzIMhB4dAEiCD0uIMxda3u-PKQuQv5IjHce54FHHHrgTRO0UzX2QudLQ~9ae3202bfd3952d4add74d4c0160d89b

Analyst Recommendations on NuCana plc

American Depositary Receipts of European Equities Advance Slightly Before US Rate Decision MT
ECB, Bank of England Interest Rate Hikes Weigh Down European Equities MT
Oppenheimer Trims NuCana's Price Target to $4 From $5, Maintains Outperform Rating MT
Jefferies & Co. Adjusts NuCana's Price Target to $3 From $21, Keeps Buy Rating MT
Truist Securities Adjusts NuCana's Price Target to $6 From $22, Reiterates Buy Rating MT
Oppenheimer Adjusts NuCana Price Target to $5 From $19, Maintains Neutral Rating MT
Cowen Downgrades NuCana to Market Perform From Outperform MT
HC Wainwright Adjusts NuCana's Price Target to $9 From $10, Keeps Buy Rating MT
NUCANA : HC Wainwright Adjusts NuCana's Price Target to $10 From $15, Keeps at Buy MT
NuCana : Says Final Data From Phase Ib Trial of Advanced Biliary Tract Cancer Treatment Show High Objective Response Rate MT
NUCANA : HC Wainwright Adjusts NuCana's Price Target to $15 From $17, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.98 USD
Average target price
119.8 USD
Spread / Average Target
+2,910.89%
High Price Target
150 USD
Spread / Highest target
+3,668.84%
Low Price Target
100 USD
Spread / Lowest Target
+2,412.56%

Consensus detail

Consensus revision (last 18 months)

Analysts covering NuCana plc

Oppenheimer
Jefferies & Co.
Truist Securities
Cowen
HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NCNA Stock
  4. Consensus NuCana plc